Sven Van Brandt

1.0k total citations
28 papers, 717 citations indexed

About

Sven Van Brandt is a scholar working on Surgery, Hematology and Molecular Biology. According to data from OpenAlex, Sven Van Brandt has authored 28 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Sven Van Brandt's work include Heparin-Induced Thrombocytopenia and Thrombosis (9 papers), Platelet Disorders and Treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Sven Van Brandt is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (9 papers), Platelet Disorders and Treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Sven Van Brandt collaborates with scholars based in Germany, Belgium and United States. Sven Van Brandt's co-authors include Andreas Greinacher, Krystin Krauel, Christiane A. Helm, Stephan Block, Sven Hammerschmidt, Mihaela Delcea, Thomas Renné, Claudia E. Weber, Ulrich Zähringer and Uwe Mamat and has published in prestigious journals such as Blood, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Sven Van Brandt

27 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Van Brandt Germany 16 331 278 156 135 115 28 717
Tereza Bârzu France 12 161 0.5× 126 0.5× 231 1.5× 11 0.1× 132 1.1× 24 696
Giang Lê Minh United States 13 62 0.2× 213 0.8× 151 1.0× 16 0.1× 107 0.9× 19 558
Sanjay Khandelwal United States 15 219 0.7× 223 0.8× 80 0.5× 72 0.5× 71 0.6× 33 616
Bock Lim Australia 13 113 0.3× 113 0.4× 293 1.9× 4 0.0× 53 0.5× 16 807
Daniel Yacoub Canada 14 85 0.3× 190 0.7× 136 0.9× 8 0.1× 43 0.4× 20 609
Jogin R. Wu United States 13 254 0.8× 192 0.7× 106 0.7× 95 0.7× 70 0.6× 18 612
Marie Loosveld France 14 116 0.4× 194 0.7× 199 1.3× 5 0.0× 76 0.7× 46 753
Femke Noorman Netherlands 13 47 0.1× 146 0.5× 105 0.7× 78 0.6× 12 0.1× 30 585
O.R. Ødegård Norway 13 167 0.5× 620 2.2× 124 0.8× 9 0.1× 178 1.5× 21 1.0k
Annabelle Dupont France 15 103 0.3× 63 0.2× 152 1.0× 19 0.1× 38 0.3× 32 600

Countries citing papers authored by Sven Van Brandt

Since Specialization
Citations

This map shows the geographic impact of Sven Van Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Van Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Van Brandt more than expected).

Fields of papers citing papers by Sven Van Brandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Van Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Van Brandt. The network helps show where Sven Van Brandt may publish in the future.

Co-authorship network of co-authors of Sven Van Brandt

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Van Brandt. A scholar is included among the top collaborators of Sven Van Brandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Van Brandt. Sven Van Brandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bischoff, François, Sven Van Brandt, Rodrigo J. Carbajo, et al.. (2025). Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo Exploration. Journal of Medicinal Chemistry. 68(4). 4672–4693. 1 indexed citations
2.
Peschiulli, Aldo, Daniel Oehlrich, Michiel Van Gool, et al.. (2021). A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo. ACS Medicinal Chemistry Letters. 13(1). 76–83. 7 indexed citations
3.
Rombouts, Frederik, Chien‐Chi Hsiao, Sven Van Brandt, et al.. (2021). Modulating physicochemical properties of tetrahydropyridine-2-amine BACE1 inhibitors with electron-withdrawing groups: A systematic study. European Journal of Medicinal Chemistry. 228. 114028–114028. 3 indexed citations
4.
Oehlrich, Daniel, Aldo Peschiulli, Gary Tresadern, et al.. (2019). Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads. ACS Medicinal Chemistry Letters. 10(8). 1159–1165. 26 indexed citations
5.
Bischoff, François, Serge Pieters, Didier Berthelot, et al.. (2019). Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 29(14). 1737–1745. 6 indexed citations
6.
Nguyen, Thi‐Huong, Yongmei Xu, Sven Van Brandt, et al.. (2019). Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins. Journal of Thrombosis and Haemostasis. 18(2). 390–398. 16 indexed citations
7.
Krauel, Krystin, Theodore E. Warkentin, Sven Van Brandt, et al.. (2018). Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT. Blood. 133(9). 978–989. 15 indexed citations
8.
Gijsen, Harrie J. M., Gregor J. Macdonald, Daniel Oehlrich, et al.. (2018). Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate. Journal of Medicinal Chemistry. 61(12). 5292–5303. 11 indexed citations
9.
10.
Wesche, Jan, Anne Grotevendt, Sven Van Brandt, et al.. (2015). Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets. Thrombosis and Haemostasis. 115(2). 324–332. 4 indexed citations
11.
Brandt, Sven Van, Krystin Krauel, Thomas Renné, et al.. (2015). Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria. Thrombosis and Haemostasis. 114(12). 1189–1198. 40 indexed citations
12.
Brandt, Sven Van, Krystin Krauel, Stephan Block, et al.. (2014). Binding of anti–platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. Blood. 124(15). 2442–2449. 55 indexed citations
13.
Bischoff, François, Didier Berthelot, Daniel Oehlrich, et al.. (2014). Anilinotriazoles as potent gamma secretase modulators. Bioorganic & Medicinal Chemistry Letters. 24(24). 5805–5813. 12 indexed citations
14.
Brandt, Sven Van, Krystin Krauel, Kay E. Gottschalk, et al.. (2014). Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity. Thrombosis and Haemostasis. 112(7). 53–64. 63 indexed citations
15.
Oehlrich, Daniel, Frederik Rombouts, Didier Berthelot, et al.. (2013). Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 23(17). 4794–4800. 15 indexed citations
16.
Bakchoul, Tamam, Jean Amiral, Simon Panzer, et al.. (2013). Anti–protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis. Blood. 121(15). 2821–2827. 49 indexed citations
17.
Lode, Holger N., Manuela Schmidt, Diana Seidel, et al.. (2013). Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response. Cancer Immunology Immunotherapy. 62(6). 999–1010. 39 indexed citations
18.
Bischoff, François, Didier Berthelot, Gregor J. Macdonald, et al.. (2012). Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators. Journal of Medicinal Chemistry. 55(21). 9089–9106. 49 indexed citations
19.
Hamid, Rizwan, John D. Patterson, & Sven Van Brandt. (2008). Genomic structure, alternative splicing and expression of TG-interacting factor, in human myeloid leukemia blasts and cell lines. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1779(5). 347–355. 33 indexed citations
20.
Ruffner, Katherine, Dennis C. Stokes, William Ka Kei Wu, et al.. (2006). Allogeneic hematopoietic stem cell transplant (HSCT) in adults with acute myeloid leukemia (AML) – a single program experience. Biology of Blood and Marrow Transplantation. 12(2). 88–88. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tereza Bârzu Breakdown of academic impact, for papers by Giang Lê Minh Breakdown of academic impact, for papers by Sanjay Khandelwal Breakdown of academic impact, for papers by Bock Lim Breakdown of academic impact, for papers by Daniel Yacoub Breakdown of academic impact, for papers by Jogin R. Wu Breakdown of academic impact, for papers by Marie Loosveld Breakdown of academic impact, for papers by Femke Noorman Breakdown of academic impact, for papers by O.R. Ødegård Breakdown of academic impact, for papers by Annabelle Dupont
Rankless by CCL
2026